Cloning and characterization of the presenilin-2 gene promoter

Molecular Brain Research

Volumn 56, Issue 1-2, 1998, Pages 57-65

  Pennypacker, K R ^a   Fuldner, R ^b   Xu, R ^a   Hernandez, H ^a   Dawbarn, D ^c   Mehta, N ^d   Perez Tur, J ^d   Baker, M ^d   Hutton, M ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Nerve growth factor; Presenilin; Promoter

Indexed keywords

NERVE GROWTH FACTOR; PRESENILIN 2; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DEVELOPMENT; GERMANY; HOUSEKEEPING GENE; HUMAN; ITALY; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIMIAN VIRUS 40; TATA BOX; TRANSCRIPTION REGULATION;

5' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PRESENILIN-2; PROMOTER REGIONS (GENETICS); RATS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0032077495     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00028-X     Document Type: Article

References (33)

1. Anderson A., Cummings B., Cotman C. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology. Exp. Pathol. 125:1994;286-295.
2. Ayoubi T.A., Van De Ven W.J. Regulation of gene expression by alternative promoters. FASEB J. 10:1996;453-460.
3. Benkovic S., McGowan E., Rothwell N., Hutton M., Morgan D., Gordon M. Regional and cellular localization of the presenilin-2 RNA in rat and human brain. Exp. Neurol. 145:1997;555-564.
4. Clarke R., Hutton M., Fuldner R., Froelich S., Karran E., Talbot C., Crook R., Lendon C., Prihar G., He C., Korenblat K., Martinez A., Wragg M., Busfield F., Behrens M., Myers A., Norton J., Morris J., Mehta N., Pearson C., Lincoln S., Baker M., Duff K., Zehr C., Perez-Tur J., Houlden H., Ruiz A., Ossa J., Lopera F., Arcos M., Madriga L., Collinge J., Humphreys C., Ashworth A., Sarner S., Fox N., Harvey R., Kennedy A., Roques P., Cline R., Phillips C., Venter J., Forsell L., Axelman K., Lilius L., Johnston J., Cowburn R., Viitanen M., Winblad B., Kosik K., Haltia M., Poyhonen M., Dickson D., Mann D., Neary D., Snowden J., Lantos P., Lannfelt L., Rossor M., Roberts G., Adams M., Hardy J., Goate A. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat. Genet. 11:1995;219-222.
5. Cribbs D., Chen L., Cotman C., LaFeria F. Injury induces presenilin-1 gene expression in mouse brain. NeuroReport. 7:1996;1773-1776.
6. Hardy J. The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc. Natl. Acad. Sci. U.S.A. 94:1997;2095-2097.
7. Hartmann H., Busciglio J., Baumann K., Staufenbiel M., Yankner B. Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J. Biol. Chem. 272:1997;14505-14508.
8. Hong C., Koo E. Genetic dissection of presenilin functions in a neuronal cell line. Neurosci. Abstr. 22:1996;1662.
9. Imagawa M., Chiu R., Karin M. Transcription factor AP-2 mediates two different signal transduction pathways: protein kinase C and cAMP. Cell. 51:1987;251-260.
10. Kahle P., Mangold M., Kuwahara T., Schubenal R., Hertel C. Protein kinase inhibitor H-7 differentially affects early and delayed nerve growth factor responses in PC12 cells. J. Neurochem. 62:1994;479-488.
11. Kovacs D., Fausett H., Page K., Kim T., Moir R., Merriam D., Hollister R., Hallmark O., Mancini R., Felsenstein K., Hyman B., Tanzi R., Wasco W. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:1996;224-229.
12. Lee M., Slunt H., Martin L., Thinkaran G., Kim G., Gandy S., Seeger M., Koo E., Price D., Sisodia S. Expression of presenilin 1 and 2 (PS-1 and PS-2) in human and murine tissues. J. Neurosci. 16:1996;7513-7525.
13. Levy-Lahad E., Wasco W., Poorkaj P., Romano D., Oshima J., Pettingell W., Yu C., Jondro P., Schmidt S., Wang K., Crowley A., Fu Y.-H., Guenette S., Galas D., Nemens E., Wijsman E., Bird T., Schellenberg G., Tanzi R. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
14. McMillian P., Leverenz J., Poorkaj P., Schellenberg G., Dorsa D. Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease. J. Histochem. Cytochem. 44:1996;1215-1222.
15. Molina C., Foulkes N., Lalli E., Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell. 75:1993;875-886.
16. Muhlethaler-Mottet A., Otten L., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860.
17. Pennypacker K. Transcription factors in brain injury. Histochem. Histopathol. 12:1997;1125-1133.
18. Pennypacker K., Hong J., McMillian M. Implications of prolonged expression of Fos-related antigens. TIPS. 16:1995;317-321.
19. Perez-Otano I., McMillian M., Chen J., Bing G., Hong J., Pennypacker K. Induction of NFkB-like transcription factors in brain areas susceptible to kainate toxicity. Glia. 16:1996;306-315.
20. Pollwein P., Masters C.L., Beyreuther K. The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter. Nucleic Acids Res. 20:1991;63-68.
21. Pollwein P. Overlapping binding sites of two different transcription factors in the promoter of the human gene for the Alzheimer amyloid precursor protein. Biochem. Biophys. Res. Commun. 190:1992;637-647.
22. Powis G., Briehl M., Oblong J. Redox signaling and the control of cell growth and death. Pharmacol. Ther. 68:1995;149-173.
23. Pugh B., Tjian R. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5:1991;1935-1945.
24. Rogaev E., Sherrington R., Rogaeva E., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P., Rommens J., St George-Hyslop P. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
25. Schibler U., Sierra F. Alternative promoters in developmental gene expression. Annu. Rev. Genet. 21:1987;237-257.
26. Sherrington R., Rogaev E., Liang Y., Rogaeva E., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A., Montesi M., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Saneau P., Polinsky R., Wasco W., Da Silva H., Haines J., Pericak-Vance M., Tanzi R., Roses A., Fraser P., Rommens J., St George-Hyslop P. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
27. Singh K., Taylor L., Campbell X., Fields A., Neet K. A bryostatin-sensitive protein kinase C required for nerve growth factor activity. Biochemistry. 33:1994;542-551.
28. Takami K., Terai K., Matsuo A., Walker D., McGeer P. Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains. Brain Res. 748:1997;122-130.
29. Terai K., Matsuo A., McGeer P. Enhancement of immunoreactivity for NF-kB in the hippocampal formation and cerebral cortex of Alzheimer disease. Brain Res. 735:1996;159-168.
30. Wang G., Jiang B.-H., Semenza G. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 212:1995;550-556.
31. Wang G., Semenza G. Oxygen sensing and response to hypoxia by mammalian cells. Redox Rep. 2:1996;89-96.
32. Wolozin B., Iwasaki K., Vito P., Ganjei J., Lacana E., Sunderland T., Zhao B., Kusiak J., Wasco W., D'Adamio L. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-1713.
33. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., Sisodia S.S. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 387:1997;288-292.